Versor Investments’s BioTelemetry, Inc. BEAT Stock Holding History

Versor Investments’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-48,221	Closed	-$3.48M	–	276
2020 Q4	$3.48M	Buy	+48,221	New	+$2.52M	0.31%	23

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Versor Investments's BEAT Position: Q1 2021 in Review

Versor Investments sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 48,221 shares — an estimated $3.48M sold.

Versor Investments first reported a position in BEAT in Q4 2020 and held it in 1 quarter. The position peaked at $3.48M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Versor Investments reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Versor Investments sold 48,221 BioTelemetry, Inc. shares in Q1 2021, an estimated $3.48M.
Versor Investments first reported a position in BioTelemetry, Inc. in Q4 2020 and held it in 1 quarter.
Versor Investments's BioTelemetry, Inc. position peaked at $3.48M in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Versor Investments's 13F filing for Q1 2021, filed 10 May 2021.